966 related articles for article (PubMed ID: 28735000)
1. Application of pharmacometrics and quantitative systems pharmacology to cancer therapy: The example of luminal a breast cancer.
Fleisher B; Brown AN; Ait-Oudhia S
Pharmacol Res; 2017 Oct; 124():20-33. PubMed ID: 28735000
[TBL] [Abstract][Full Text] [Related]
2. Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids.
Ayyar VS; Jusko WJ
Pharmacol Rev; 2020 Apr; 72(2):414-438. PubMed ID: 32123034
[TBL] [Abstract][Full Text] [Related]
3. Translational Quantitative Systems Pharmacology in Drug Development: from Current Landscape to Good Practices.
Bai JPF; Earp JC; Pillai VC
AAPS J; 2019 Jun; 21(4):72. PubMed ID: 31161268
[TBL] [Abstract][Full Text] [Related]
4. Physiological Indirect Response Model to Omics-Powered Quantitative Systems Pharmacology Model.
Uatay A; Gall L; Irons L; Tewari SG; Zhu XS; Gibbs M; Kimko H
J Pharm Sci; 2024 Jan; 113(1):11-21. PubMed ID: 37898164
[TBL] [Abstract][Full Text] [Related]
5. Combining Multiscale Experimental and Computational Systems Pharmacological Approaches to Overcome Resistance to HER2-targeted Therapy in Breast Cancer.
Vaidya TR; Ande A; Ait-Oudhia S
J Pharmacol Exp Ther; 2019 Jun; 369(3):531-545. PubMed ID: 30898866
[TBL] [Abstract][Full Text] [Related]
6. Virtual Populations for Quantitative Systems Pharmacology Models.
Cheng Y; Straube R; Alnaif AE; Huang L; Leil TA; Schmidt BJ
Methods Mol Biol; 2022; 2486():129-179. PubMed ID: 35437722
[TBL] [Abstract][Full Text] [Related]
7. Using quantitative systems pharmacology for novel drug discovery.
Pérez-Nueno VI
Expert Opin Drug Discov; 2015 Dec; 10(12):1315-31. PubMed ID: 26328768
[TBL] [Abstract][Full Text] [Related]
8. Introduction: Cancer Gene Networks.
Clarke R
Methods Mol Biol; 2017; 1513():1-9. PubMed ID: 27807826
[TBL] [Abstract][Full Text] [Related]
9. Integration not isolation: arguing the case for quantitative and systems pharmacology in drug discovery and development.
Agoram BM; Demin O
Drug Discov Today; 2011 Dec; 16(23-24):1031-6. PubMed ID: 22020181
[TBL] [Abstract][Full Text] [Related]
10. Boolean network modeling in systems pharmacology.
Bloomingdale P; Nguyen VA; Niu J; Mager DE
J Pharmacokinet Pharmacodyn; 2018 Feb; 45(1):159-180. PubMed ID: 29307099
[TBL] [Abstract][Full Text] [Related]
11. Recent applications of quantitative systems pharmacology and machine learning models across diseases.
Aghamiri SS; Amin R; Helikar T
J Pharmacokinet Pharmacodyn; 2022 Feb; 49(1):19-37. PubMed ID: 34671863
[TBL] [Abstract][Full Text] [Related]
12. The convergence of pharmacometrics and quantitative systems pharmacology in pharmaceutical research and development.
Joshi A; Ramanujan S; Jin JY
Eur J Pharm Sci; 2023 Mar; 182():106380. PubMed ID: 36638898
[TBL] [Abstract][Full Text] [Related]
13. Bringing Model-Based Prediction to Oncology Clinical Practice: A Review of Pharmacometrics Principles and Applications.
Buil-Bruna N; López-Picazo JM; Martín-Algarra S; Trocóniz IF
Oncologist; 2016 Feb; 21(2):220-32. PubMed ID: 26668254
[TBL] [Abstract][Full Text] [Related]
14. [An introduction to QSP modeling for pharmacologists].
Sayama H; Nagasaka Y; Tabata K
Nihon Yakurigaku Zasshi; 2019; 154(3):143-150. PubMed ID: 31527365
[TBL] [Abstract][Full Text] [Related]
15. Drug-disease modeling in the pharmaceutical industry - where mechanistic systems pharmacology and statistical pharmacometrics meet.
Helmlinger G; Al-Huniti N; Aksenov S; Peskov K; Hallow KM; Chu L; Boulton D; Eriksson U; Hamrén B; Lambert C; Masson E; Tomkinson H; Stanski D
Eur J Pharm Sci; 2017 Nov; 109S():S39-S46. PubMed ID: 28506868
[TBL] [Abstract][Full Text] [Related]
16. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
17. Towards Quantitative Systems Pharmacology Models of Chemotherapy-Induced Neutropenia.
Craig M
CPT Pharmacometrics Syst Pharmacol; 2017 May; 6(5):293-304. PubMed ID: 28418603
[TBL] [Abstract][Full Text] [Related]
18. From Cold to Hot: Changing Perceptions and Future Opportunities for Quantitative Systems Pharmacology Modeling in Cancer Immunotherapy.
Lemaire V; Bassen D; Reed M; Song R; Khalili S; Lien YTK; Huang L; Singh AP; Stamatelos S; Bottino D; Hua F
Clin Pharmacol Ther; 2023 May; 113(5):963-972. PubMed ID: 36282521
[TBL] [Abstract][Full Text] [Related]
19. Biomarker-based drug safety assessment in the age of systems pharmacology: from foundational to regulatory science.
Zhang C; Hong H; Mendrick DL; Tang Y; Cheng F
Biomark Med; 2015; 9(11):1241-52. PubMed ID: 26506997
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
